Neoadjuvant therapy and sleeve lobectomy for locally advanced non-small cell lung cancer: morbidity and survival balancing
- PMID: 38738237
- PMCID: PMC11087599
- DOI: 10.21037/jtd-24-23
Neoadjuvant therapy and sleeve lobectomy for locally advanced non-small cell lung cancer: morbidity and survival balancing
Keywords: Induction therapy; advanced lung cancer; bronchoplasty; complications; sleeve lobectomy.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-23/coif). The authors have no conflicts of interest to declare.
Comment on
-
Neoadjuvant therapy does not increase postoperative morbidity of sleeve lobectomy in locally advanced non-small cell lung cancer.J Thorac Cardiovasc Surg. 2023 Oct;166(4):1234-1244.e13. doi: 10.1016/j.jtcvs.2023.03.016. Epub 2023 Mar 24. J Thorac Cardiovasc Surg. 2023. PMID: 36965521
References
Publication types
LinkOut - more resources
Full Text Sources